NO911609L - Veksthormon-frigjoerende faktoranaloger. - Google Patents

Veksthormon-frigjoerende faktoranaloger.

Info

Publication number
NO911609L
NO911609L NO91911609A NO911609A NO911609L NO 911609 L NO911609 L NO 911609L NO 91911609 A NO91911609 A NO 91911609A NO 911609 A NO911609 A NO 911609A NO 911609 L NO911609 L NO 911609L
Authority
NO
Norway
Prior art keywords
releasing factor
compounds
analogs
factor analogs
growth hormone
Prior art date
Application number
NO91911609A
Other languages
English (en)
Norwegian (no)
Other versions
NO911609D0 (no
Inventor
Gerald Stephen Brooke
Richard Dennis Dimarchi
Mark Louis Heiman
Hansen Maxwell Hsiung
David Lee Smiley
Dennis Paul Smith
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO911609D0 publication Critical patent/NO911609D0/no
Publication of NO911609L publication Critical patent/NO911609L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Pens And Brushes (AREA)
  • Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO91911609A 1990-04-24 1991-04-23 Veksthormon-frigjoerende faktoranaloger. NO911609L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51373090A 1990-04-24 1990-04-24
US58732390A 1990-09-24 1990-09-24

Publications (2)

Publication Number Publication Date
NO911609D0 NO911609D0 (no) 1991-04-23
NO911609L true NO911609L (no) 1991-10-25

Family

ID=27057991

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911609A NO911609L (no) 1990-04-24 1991-04-23 Veksthormon-frigjoerende faktoranaloger.

Country Status (18)

Country Link
EP (1) EP0454367B1 (hu)
JP (1) JPH04305598A (hu)
KR (1) KR910018546A (hu)
CN (1) CN1066345C (hu)
AT (1) ATE186570T1 (hu)
AU (1) AU643773B2 (hu)
CA (1) CA2040649A1 (hu)
DE (1) DE69131771T2 (hu)
DK (1) DK0454367T3 (hu)
ES (1) ES2141085T3 (hu)
FI (1) FI911961A (hu)
GR (1) GR3032384T3 (hu)
HU (1) HUT60634A (hu)
IE (1) IE911358A1 (hu)
IL (1) IL97885A0 (hu)
NO (1) NO911609L (hu)
NZ (1) NZ237857A (hu)
PT (1) PT97414A (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973114A (en) * 1992-06-23 1999-10-26 The University Of Virginia Patent Foundation Isolation and characterization of the growth hormone releasing hormone receptor
WO2012142706A1 (en) * 2011-04-21 2012-10-26 Theratechnologies Inc. Growth hormone releasing factor (grf) analogs and uses thereof
CN109180800B (zh) * 2018-08-01 2019-07-12 广东药科大学 新型生长激素释放激素类似肽二聚体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728609A (en) 1983-01-10 1988-03-01 Hoffmann-La-Roche Inc. Recombinant growth hormone releasing factor
US4617149A (en) 1983-09-21 1986-10-14 Eli Lilly And Company Growth hormone release factor analogs
IT1234977B (it) 1985-03-22 1992-06-09 Serono Ist Farm Espressione in e. coli polipeptidi ibridi contenenti la sequenza del fattore di rilascio dell'ormone della crescita
US4734399A (en) 1985-08-06 1988-03-29 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
PT83613B (en) 1985-10-28 1988-11-21 Lilly Co Eli Process for the selective chemical removal of a protein amino-terminal residue
IL86102A (en) * 1987-05-11 1994-04-12 Univ Tulane Alkylated peptides that release growth hormone and their use
IL91771A0 (en) * 1988-09-30 1990-06-10 Lilly Co Eli Increased expression of small molecular weight recombinant proteins

Also Published As

Publication number Publication date
ATE186570T1 (de) 1999-11-15
JPH04305598A (ja) 1992-10-28
IL97885A0 (en) 1992-06-21
IE911358A1 (en) 1991-11-06
EP0454367A3 (en) 1992-07-29
KR910018546A (ko) 1991-11-30
GR3032384T3 (en) 2000-04-27
CN1066345C (zh) 2001-05-30
DE69131771T2 (de) 2000-04-06
AU643773B2 (en) 1993-11-25
DE69131771D1 (de) 1999-12-16
CA2040649A1 (en) 1991-10-25
ES2141085T3 (es) 2000-03-16
HU911358D0 (en) 1991-10-28
EP0454367A2 (en) 1991-10-30
AU7525091A (en) 1991-11-07
FI911961A (fi) 1991-10-25
PT97414A (pt) 1992-01-31
EP0454367B1 (en) 1999-11-10
NZ237857A (en) 1992-05-26
NO911609D0 (no) 1991-04-23
HUT60634A (en) 1992-10-28
FI911961A0 (fi) 1991-04-23
DK0454367T3 (da) 2000-03-27
CN1057784A (zh) 1992-01-15

Similar Documents

Publication Publication Date Title
DE69033040D1 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
EP0355460A3 (en) Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization
DE69027989D1 (de) Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON
DE3588095D1 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
NO165804C (no) Veksthormon-frigjoerende peptider og anvendelse derav.
DK0585939T3 (da) TNF-ligander
PT87523A (pt) Mischkristalle aus insulin und insulinderivaten verfahren zur herstellung dieser mischkristalle diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
HUT62605A (en) Process for producing polypeptide compounds promoting release of growth hormone
DE69131771D1 (de) Wachstumshormon-Releasingfaktor-Analoge
DE3270446D1 (en) Diamides of substituted hydroxymalonic acids, process for their preparation and their use as pesticides
DE69032323D1 (de) Produktion und verwendung von antihelmintischen substanzen und schützenden immunogenen
DK13888A (da) Krystallinsk cefadroxil, fremgangsmaade til dets fremstilling, og farmaceutisk praeparat indeholdende et saadant
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
DE68905097D1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
PT87628A (pt) Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives
DE69017146D1 (de) Verfahren zur Herstellung von 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbonsäurethioamid-1-(1R,2R)oxyden, die so erhaltenen 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbothioamid-1-(1R,2R)oxyde und diese enthaltende pharmazeutische Zusammenstellungen.
YU73891A (sh) Analozi faktora koji oslobadjaju hormon rasta
DE3889143D1 (de) Verfahren zur Herstellung von L-Phenylalanin durch rekombinantes E.coli.